These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25823858)

  • 1. Early pulmonary inflammation and lung damage in children with cystic fibrosis.
    Schultz A; Stick S
    Respirology; 2015 May; 20(4):569-78. PubMed ID: 25823858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.
    Pezzulo AA; Tang XX; Hoegger MJ; Abou Alaiwa MH; Ramachandran S; Moninger TO; Karp PH; Wohlford-Lenane CL; Haagsman HP; van Eijk M; Bánfi B; Horswill AR; Stoltz DA; McCray PB; Welsh MJ; Zabner J
    Nature; 2012 Jul; 487(7405):109-13. PubMed ID: 22763554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study.
    Abou Alaiwa MH; Beer AM; Pezzulo AA; Launspach JL; Horan RA; Stoltz DA; Starner TD; Welsh MJ; Zabner J
    J Cyst Fibros; 2014 Jul; 13(4):373-7. PubMed ID: 24418186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of CFTR in airway disease.
    Pilewski JM; Frizzell RA
    Physiol Rev; 1999 Jan; 79(1 Suppl):S215-55. PubMed ID: 9922383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular pH and lung infections in cystic fibrosis.
    Massip-Copiz MM; Santa-Coloma TA
    Eur J Cell Biol; 2018 Aug; 97(6):402-410. PubMed ID: 29933921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFTR, mucins, and mucus obstruction in cystic fibrosis.
    Kreda SM; Davis CW; Rose MC
    Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009589. PubMed ID: 22951447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inflammation and cystic fibrosis].
    Delacourt C
    Arch Pediatr; 2003 Sep; 10 Suppl 2():338s-341s. PubMed ID: 14671931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis transmembrane conductance regulator is expressed in mucin granules from Calu-3 and primary human airway epithelial cells.
    LeSimple P; Goepp J; Palmer ML; Fahrenkrug SC; O'Grady SM; Ferraro P; Robert R; Hanrahan JW
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):511-6. PubMed ID: 23742042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment.
    Poschet J; Perkett E; Deretic V
    Trends Mol Med; 2002 Nov; 8(11):512-9. PubMed ID: 12421684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and the cystic fibrosis gender gap.
    Saint-Criq V; Harvey BJ
    Steroids; 2014 Mar; 81():4-8. PubMed ID: 24342234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological impact of abnormal lipoxin A₄ production on cystic fibrosis airway epithelium and therapeutic potential.
    Higgins G; Ringholz F; Buchanan P; McNally P; Urbach V
    Biomed Res Int; 2015; 2015():781087. PubMed ID: 25866809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathology of Airway Surface Liquid Dehydration Disease.
    Lewis BW; Patial S; Saini Y
    J Immunol Res; 2019; 2019():2180409. PubMed ID: 31396541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.
    Verkman AS; Song Y; Thiagarajah JR
    Am J Physiol Cell Physiol; 2003 Jan; 284(1):C2-15. PubMed ID: 12475759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.
    Hsu D; Taylor P; Fletcher D; van Heeckeren R; Eastman J; van Heeckeren A; Davis P; Chmiel JF; Pearlman E; Bonfield TL
    Infect Immun; 2016 Sep; 84(9):2410-21. PubMed ID: 27271746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling.
    Bruscia EM; Zhang PX; Barone C; Scholte BJ; Homer R; Krause DS; Egan ME
    Am J Physiol Lung Cell Mol Physiol; 2016 Apr; 310(8):L711-9. PubMed ID: 26851259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation in cystic fibrosis: An update.
    Roesch EA; Nichols DP; Chmiel JF
    Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating gel-forming mucins' roles in cystic fibrosis lung disease.
    Perez-Vilar J; Boucher RC
    Free Radic Biol Med; 2004 Nov; 37(10):1564-77. PubMed ID: 15477008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.